OVEREXPRESSION OF MATRIX METALLOPROTEINASE-12 (MMP-12) AS A DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA
Mohammed, L., Abdel-kareem, M., Sakr, M., Elshemi, E. (2015). OVEREXPRESSION OF MATRIX METALLOPROTEINASE-12 (MMP-12) AS A DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA. EKB Journal Management System, 1(2), 44-54. doi: 10.21608/rjab.2015.104420
Lobna Mohammed; Mohammed Y. Abdel-kareem; Moustafa A. Sakr; Essam Elshemi. "OVEREXPRESSION OF MATRIX METALLOPROTEINASE-12 (MMP-12) AS A DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA". EKB Journal Management System, 1, 2, 2015, 44-54. doi: 10.21608/rjab.2015.104420
Mohammed, L., Abdel-kareem, M., Sakr, M., Elshemi, E. (2015). 'OVEREXPRESSION OF MATRIX METALLOPROTEINASE-12 (MMP-12) AS A DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA', EKB Journal Management System, 1(2), pp. 44-54. doi: 10.21608/rjab.2015.104420
Mohammed, L., Abdel-kareem, M., Sakr, M., Elshemi, E. OVEREXPRESSION OF MATRIX METALLOPROTEINASE-12 (MMP-12) AS A DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA. EKB Journal Management System, 2015; 1(2): 44-54. doi: 10.21608/rjab.2015.104420

OVEREXPRESSION OF MATRIX METALLOPROTEINASE-12 (MMP-12) AS A DIAGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA

Research Journal of Applied Biotechnology
Article 5, Volume 1, Issue 2, November 2015, Page 44-54  XML PDF (956.2 K)
Document Type: Original Article
DOI: 10.21608/rjab.2015.104420
View on SCiNiTO View on SCiNiTO
Authors
Lobna Mohammed1; Mohammed Y. Abdel-kareem2; Moustafa A. Sakr email orcid 1; Essam Elshemi2
1Department of Molecular Diagnostics and Therapeutics, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat city, Sadat city, Egypt
2Hepatology department-National Liver Institute - Menoufia University, Egypt
Abstract
Matrix metalloproteinase-12(MMP-12) is involved in tumor invasiveness and metastasis and significantly over-expressed in tissues of HCC. The Aim was to investigate the diagnostic and prognostic value of non-invasive MMP-12 expression in human HCC patients from whole blood.The study was conducted on; 50 patients with chronic HCV related HCC, 50 patients with HCV related cirrhosis and 50 healthy persons as a control group recruited from the National Liver institute, Menoufia University, Egypt. All patients were subjected to tri-phasic CT abdomen when indicated, liver profile, AFP and Molecular characterization of metalloproteinase-12 expression by (qRT-PCR) quantitative real time PCR. We found that, there was statistically significant differences between HCC and cirrhotic patients versus control group regarding CBC parameters and liver profile, (p- value < 0.01), while there was no differences between all groups regarding creatinin (p- value > 0.05). There was a statistically significant difference between HCC patients and other groups regarding mRNAMMP12 (p- value < 0.01). The Sensitivity of MMP12 to detect HCC cases was 72.0 %, and specificity 60.0 %, with accuracy 70.9 %, P value <0.01, mRNA-MMP12 and/or AFP had sensitivity of 84.0 %, specificity 60.0 %, PPV of 51.2%, NPP 88.2 % and Accuracy 71.3 %. In Conclusion: mRNA-MMP12 is a good sensitive, bad specific but accurate in diagnosing HCC. Adding mRNA-MMP12 to AFP improves early diagnosis and hence better prognosis.

Keywords
HCV; HCC; MMP12; Egyptian patients
Statistics
Article View: 125
PDF Download: 290